SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-304196
Filing Date
2020-11-27
Accepted
2020-11-27 08:01:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d42485ds3.htm S-3 182098
2 EX-5.1 d42485dex51.htm EX-5.1 7482
3 EX-23.1 d42485dex231.htm EX-23.1 1654
4 GRAPHIC g42485dsp32_logo2.jpg GRAPHIC 3753
5 GRAPHIC g42485g04v25.jpg GRAPHIC 34528
  Complete submission text file 0001193125-20-304196.txt   245282
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-250992 | Film No.: 201352851
SIC: 2836 Biological Products, (No Diagnostic Substances)